Article
The hottest stories in clinical diagnosis this year included Grand Round cases and a new methodology for diagnosing keratoconus.
Female presents after thrombotic cerebrovascular accident . . . what’s the diagnosis?
Ophthalmology Times Editorial Advisory Board Member Sharon Fekrat, MD, FACS shared her thoughts as to why this story was so popular this past year.
“Hydroxychloroquine continues to be a commonly used oral agent for the treatment of rheumatoid arthritis and lupus, and as such, medical professionals across all specialties should be aware of the potential of a dose-dependent ocular toxicity, albeit rare, so as to promote early detection and thus avoid irreversible visual loss,” she said.
Read the Grand Rounds story here
2. Grand Rounds: Patient has proptosis and vision loss
A 69-year-old African American man was transferred from an outside hospital, having been brought in from his nursing home for worsening left orbital proptosis of unknown duration . . . what is his diagnosis?
Ophthalmology Times Chief Medical Editor Peter J. McDonnell shared why he believes this story was a hot topic throughout 2014.
“This interesting case report has been one of the most viewed clinical diagnosis-related stories in Ophthalmology Times. It exemplifies the importance of considering underlying systemic medical disease when the ophthalmologist is faced with a patient who presents with “an eye problem”, and raises important issues such as the care of individuals who have dementia.”
In the spring, we published this story that examined a study that found Bowman's ectasia index good for diagnosing keratoconus.
“This new potential methodology for keratoconus diagnosis detects a possible pathognomonic feature of the keratoconic cornea,” said Ophthalmology Times Editorial Advisory Board Member Peter S. Hersh, MD, FACS. “If developed into a clinical diagnostic device, it would have great promise in the detection of early keratoconus.”
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.